484
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Functionalized Mesoporous Silica Nanoparticles for Drug-Delivery to Multidrug-Resistant Cancer Cells

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 3079-3096 | Published online: 14 Jul 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yu Hsia, Maharajan Sivasubramanian, Chia-Hui Chu, Yao-Chen Chuang, Yiu-Kay Lai & Leu-Wei Lo. (2023) A Dual Concentration-Tailored Cytokine-Chemo Nanosystem to Alleviate Multidrug Resistance and Redirect Balance of Cancer Proliferation and Apoptosis. International Journal of Nanomedicine 18, pages 4253-4274.
Read now

Articles from other publishers (4)

Yasir Qasim Almajidi, Mustafa M. Kadhim, Fahad Alsaikhan, Abduladheem Turki Jalil, Nidhal Hassan Sayyid, Andrés Alexis Ramírez-Coronel, Zanko Hassan Jawhar, Jitendra Gupta, Noushin Nabavi, Wei Yu & Yavuz Nuri Ertas. (2023) Doxorubicin-loaded micelles in tumor cell-specific chemotherapy. Environmental Research 227, pages 115722.
Crossref
Mariia Uzhytchak, Barbora Smolková, Mariia Lunova, Adam Frtús, Milan Jirsa, Alexandr Dejneka & Oleg Lunov. (2023) Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function. Advanced Drug Delivery Reviews 197, pages 114828.
Crossref
Jae Min Jung, Yu Lip Jung, Seong Han Kim, Doo Sung Lee & Thavasyappan Thambi. (2023) Injectable hydrogel imbibed with camptothecin-loaded mesoporous silica nanoparticles as an implantable sustained delivery depot for cancer therapy. Journal of Colloid and Interface Science 636, pages 328-340.
Crossref
Priya Yadav, Suresh V. Ambudkar & N. Rajendra Prasad. (2022) Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer. Journal of Nanobiotechnology 20:1.
Crossref